MIF and gestational diabetes: Moreover, the ratios/relationships between the concentrations of MIF to sFLT1 and ANGPT2 to MIF were altered in women at week 12 of pregnancy, which is at least 10 weeks before diagnosis of GDM, suggesting that they may serve as potential early biomarkers for GDM.